All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Peptide therapy TikTok claims: separating hype from human data

H A R I S

TikTok creator

7.6K viewsWatch on TikTok→

Quick answer

GHK-Cu is a naturally occurring copper-binding peptide with in vitro and limited human evidence supporting collagen synthesis and modest skin improvements when applied topically, though robust RCT data in healthy populations remains limited. NAD+ coenzyme supplementation has emerging evidence for metabolic and neuroprotective effects primarily in disease-state or aging populations, not in healthy adults seeking cognitive enhancement. Neither compound is FDA-approved for the cosmetic or cognitive outcomes described in this video, and both require medical supervision to use appropriately.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @hxris.h actually say?

The creator said GHK-Cu will make your hair "thicker," skin "more shinier," and "tighten the wrinkles," while NAD+ is "good for your cognitive function and your energy levels." They also pointed to their own skin as evidence, saying they're "looking a lot more younger" and "a lot more clearer." The video ends with an invitation to message them for a source to buy from, which is worth flagging immediately.

These are two distinct compounds being bundled together as the must-have stack for 2026. GHK-Cu is a naturally occurring copper peptide. NAD+ is a coenzyme, not technically a peptide at all, though it often travels in the same wellness circles. Mixing them in one "you need these" recommendation, without any dosing caveats, medical context, or disclosure of what they're actually selling, is the first problem with this video.

Does the science back this up?

For GHK-Cu specifically, there is real research here, but it is mostly in vitro and small-scale. For NAD+, the human evidence is growing but still far from settled, especially for the cognitive claims.

On GHK-Cu: Pickart and Margolina (2018, Cosmetics) summarized decades of research showing GHK-Cu stimulates collagen and glycosaminoglycan synthesis in fibroblast cultures, and a small double-blind trial by Leyden et al. (1994, Skin Pharmacology) found topical copper peptide formulations modestly improved skin laxity. However, most positive findings are in cell cultures, not randomized controlled trials in humans. The "thicker hair" claim has some backing from a study by Uno and Kurata (1993, Journal of Investigative Dermatology) showing copper peptides prolonged the anagen phase in animal models, but human trial data is thin.

On NAD+: Yoshino et al. (2021, Science) showed NMN supplementation improved muscle insulin sensitivity in postmenopausal women. Brakedal et al. (2022, Cell Metabolism) found NR raised brain NAD+ levels in Parkinson's patients. Cognitive benefits in healthy people, however, remain largely unproven in robust human trials.

What did they get wrong (or right)?

They got the general direction right on GHK-Cu and skin. The peptide does have mechanistic plausibility for collagen support and there is enough topical evidence to say it is not snake oil. Credit where it is due.

What they got wrong is the certainty. Saying it "is gonna" thicken your hair and tighten wrinkles as if these are guaranteed outcomes skips over the fact that most strong evidence is preclinical. The anecdotal "this is how my skin is looking" approach is not evidence, and presenting personal appearance as proof of a compound's efficacy is a well-worn social media tactic that misleads viewers about causation.

The NAD+ cognitive claim is the weakest link. Saying NAD+ is "good for your cognitive function" in healthy people is not well-supported by current human RCT data. The mechanism is plausible, mitochondrial energy metabolism does involve NAD+, but mechanistic plausibility and demonstrated benefit in healthy humans are not the same thing.

The call to message them for a purchase source at the end without any disclosed affiliation or medical disclaimer is a real problem, not just a nitpick.

What should you actually know?

GHK-Cu has one of the more credible research profiles in the topical peptide space. If you are considering it for skin support, the topical route has the most human evidence behind it. The hair growth claims need more human data before they should be stated as fact.

NAD+ precursors like NMN and NR are not the same as supplemental NAD+ itself, and the bioavailability of oral NAD+ is a legitimate scientific debate. Studies like Trammell et al. (2016, Nature Communications) confirmed NR raises blood NAD+ in humans, but whether that translates to the specific benefits claimed in short social media videos is a different question entirely.

Neither compound has been approved by the FDA to treat, cure, or prevent any disease. If you are considering either for a specific health concern, that conversation belongs with a licensed medical provider, not a DM thread with a TikTok creator who is offering to tell you where to buy.

  • Ask any provider about their regulatory status and whether the source is a licensed compounding pharmacy operating under appropriate oversight.
  • Be skeptical of any creator who uses their own face as clinical evidence.
  • "Do your research" is reasonable advice, but it should come before the sales pitch, not be used to offload responsibility onto the viewer.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 12 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Peptide therapy TikTok claims: separating hype from human data, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

Peptide therapy TikTok claims: separating hype from human data should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

Use the health tools and supporting evidence to prepare questions for your clinician.

Claim verdict

The useful answer behind this video

Claim being checked

GHK-Cu is a naturally occurring copper-binding peptide with in vitro and limited human evidence supporting collagen synthesis and modest skin improvements when applied topically, though robust RCT data in healthy populations remains limited.

FormBlends verdict

GHK-Cu is a naturally occurring copper-binding peptide with in vitro and limited human evidence supporting collagen synthesis and modest skin improvements when applied topically, though robust RCT data in healthy populations remains limited. NAD+ coenzyme supplementation has emerging evidence for metabolic and neuroprotective effects primarily in disease-state or aging populations, not in healthy adults seeking cognitive enhancement. Neither compound is FDA-approved for the cosmetic or cognitive outcomes described in this video, and both require medical supervision to use appropriately.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • GHK-Cu is a naturally occurring copper-binding peptide with in vitro and limited human evidence supporting collagen synthesis and modest skin improvements when applied topically, though robust RCT data in healthy populations remains limited. NAD+ coenzyme supplementation has emerging evidence for metabolic and neuroprotective effects primarily in disease-state or aging populations, not in healthy adults seeking cognitive enhancement. Neither compound is FDA-approved for the cosmetic or cognitive outcomes described in this video, and both require medical supervision to use appropriately.
  • GHK-Cu has more legitimate research backing than most peptides promoted on social media, but the strongest evidence remains in cell cultures and small human trials, not large randomized controlled studies.
  • Leyden et al. (1994) found topical copper peptides improved skin laxity in a double-blind trial, giving GHK-Cu more credibility than most cosmetic peptide ingredients, though effect sizes were modest.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • GHK-Cu has more legitimate research backing than most peptides promoted on social media, but the strongest evidence remains in cell cultures and small human trials, not large randomized controlled studies.
  • Leyden et al. (1994) found topical copper peptides improved skin laxity in a double-blind trial, giving GHK-Cu more credibility than most cosmetic peptide ingredients, though effect sizes were modest.
  • NAD+ cognitive benefit claims in healthy adults lack RCT support. Existing positive studies like Brakedal et al. (2022) focused on patients with neurological conditions, not healthy people seeking optimization.
  • Trammell et al. (2016, Nature Communications) confirmed NR supplementation raises blood NAD+ levels in humans, but elevated blood levels do not automatically translate to the brain or cognitive performance improvements.
  • The invitation to DM for a purchase source without disclosed affiliation, pricing transparency, or medical guidance is a red flag pattern common in unregulated peptide sales on social media.
  • Neither GHK-Cu nor NAD+ precursors are FDA-approved treatments for any cosmetic or cognitive condition. Use should be discussed with a licensed provider, not initiated based on a TikTok recommendation.
  • Hair thickening claims for GHK-Cu rely primarily on animal model data. Human clinical trials specifically examining hair density outcomes are limited and should not be presented as a guaranteed effect.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

H A R I S · TikTok creator

7.6K views on this video

Peptide therapy TikTok claims: separating hype from human data

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by H A R I S, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.